It didn't take long for Chris Viehbacher to jump back in to the world of drug development, although by joining the board of directors of PureTech in Boston he's swimming at the opposite end of the biopharma pool from where he was as CEO of Sanofi back in October.

Each month, Start-Up presents a comprehensive review of young, private life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.

Each month, Start-Up presents a comprehensive review of young, private life science companies that have recieved venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.